Clinical Trial Update: Proof of Concept for Real-time Multicentric Monitoring of MRD by PET and ctDNA in Aggressive B-Cell Lymphomas

View source ↗

Summary

A multicenter, proof-of-concept trial investigating real-time monitoring of minimal residual disease in aggressive B-cell lymphomas using PET imaging and circul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aggressive B-cell Lymphoma

Snippet

Sponsor: The Lymphoma Academic Research Organisation | Conditions: Aggressive B-cell Lymphomas | Status: NOT_YET_RECRUITING